Meda will syndicate €3bn loan for Rottapharm deal next week
Swedish pharmaceutical company Meda has completed the early bird syndication of its Skr28bn (€3.03bn) loan to buy Rottapharm Madaus, according to a banker at one of the leads.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: